Background/Objectives: Triple-negative breast cancer (TNBC) is characterized by the absence of the expression of estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.